229 related articles for article (PubMed ID: 3377438)
21. Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
Bisso GM; Masullo C; Michalek H; Silveri MC; Pocchiari M
Life Sci; 1986 Feb; 38(6):561-7. PubMed ID: 3945178
[TBL] [Abstract][Full Text] [Related]
22. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
Saito N
Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
[TBL] [Abstract][Full Text] [Related]
23. The significance of the activity of CSF cholinesterases in dementias.
Shen ZX
Med Hypotheses; 1996 Nov; 47(5):363-76. PubMed ID: 8951800
[TBL] [Abstract][Full Text] [Related]
24. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
25. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
Nakano S; Kato T; Nakamura S; Kameyama M
J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
[TBL] [Abstract][Full Text] [Related]
26. Serum and CSF cholinesterase activity in various kinds of dementia.
Szilágyi AK; Németh A; Martini E; Lendvai B; Venter V
Eur Arch Psychiatry Neurol Sci; 1987; 236(5):309-11. PubMed ID: 3653153
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Soininen H; Halonen T; Riekkinen PJ
Acta Neurol Scand; 1981 Sep; 64(3):217-24. PubMed ID: 7315192
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J
J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
30. Molecular forms of cholinesterases in cerebrospinal fluid, blood plasma, and brain tissue of the beagle dog.
Scarsella G; Toschi G; Bareggi SR; Giacobini E
J Neurosci Res; 1979; 4(1):19-24. PubMed ID: 423312
[TBL] [Abstract][Full Text] [Related]
31. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Atack JR; Perry EK; Bonham JR; Perry RH
J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
[TBL] [Abstract][Full Text] [Related]
32. Acetylcholinesterase activities in cerebrospinal fluid of patients with Plasmodium falciparum cerebral malaria.
Areekul S; Churdchu K; Yamarat P
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):431-4. PubMed ID: 3913001
[TBL] [Abstract][Full Text] [Related]
33. [Some data on cholinesterases in the cerebrospinal fluid of the dog].
D'Angelo P; Scarsella G
Boll Soc Ital Biol Sper; 1979 Jun; 55(11):1067-71. PubMed ID: 549583
[TBL] [Abstract][Full Text] [Related]
34. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun H; Forssell LG; Wetterberg L; Winblad B
J Neural Transm Park Dis Dement Sect; 1991; 3(4):231-58. PubMed ID: 1772577
[TBL] [Abstract][Full Text] [Related]
35. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
[TBL] [Abstract][Full Text] [Related]
36. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
[TBL] [Abstract][Full Text] [Related]
37. Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.
García-Ayllón MS; Silveyra MX; Sáez-Valero J
Chem Biol Interact; 2008 Sep; 175(1-3):209-15. PubMed ID: 18554581
[TBL] [Abstract][Full Text] [Related]
38. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Ruberg M; Rieger F; Villageois A; Bonnet AM; Agid Y
Brain Res; 1986 Jan; 362(1):83-91. PubMed ID: 3942870
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.
Strekalova H; Buhmann C; Kleene R; Eggers C; Saffell J; Hemperly J; Weiller C; Müller-Thomsen T; Schachner M
Neurobiol Aging; 2006 Jan; 27(1):1-9. PubMed ID: 16298234
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
Prohovnik I; Perl DP; Davis KL; Libow L; Lesser G; Haroutunian V
Neurology; 2006 Jan; 66(1):49-55. PubMed ID: 16401845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
